History
Icon-add-to-playlist Icon-download Icon-drawer-up
Share this ... ×
...
By ...
Embed:
Embedded player size:
Embedded player preview:
300x300_2365298
itunes pic
Icon-play-large
Episode 5: BioTalk: Emerging technologies in stem cell biology
Time-length-icon 32m 48s
Plays-icon 343
Icon-like
Publish-date-icon November 19, 2009
Icon-add-to-playlist Add to Playlist
Icon-download-mini Download Episode

Subscribe-itunes-badge
EPISODE DESCRIPTION

For this 5th episode of Bohemian Biology I uploaded one of the podcasts I produced for BioTechniques. It was originally published on Biotechniques.com June 25 2009 Run Time: 32:48

Although the ban on funding embryonic stem cells was recently lifted by President Barack Obama, the controversy over this research still remains.

New types of pluripotent stem cells have recently emerged as alternatives to embryonic stem cells. These include induced pluripotent stem cells (IPS cells) and parthenogenic stem cells.

In this episode of BioTalk, Kent Vrana (1:25) , Ph.D., chair of the department of Pharmacology at Penn State University College of Medicine, and Ken Aldrich (21:55), CEO of International Stem Cell Corporation, discuss the current state of stem cell research.

COMMENTS
You must be logged in to post a comment.
x
Embed Code
After customizing your player (optional), copy and paste the embed code above. The code will change based on your selections.
Color:

Size:
300x85
440x85
620x85
Custom
Width: px
Height: 85px

Min. width: 200px


Start playing automatically?
No Yes
Help | Terms | Privacy | Partners | PRO Support
© 2015 PodOmatic, Inc.